Apr. 11, 2019

BIOVERSYS AG AND APTUIT ANNOUNCE COLLABORATION

BioVersys AG and Aptuit have announced the start of their joint collaboration to identify novel approaches to treat serious infections from gram-negative pathogens.

German Version

French Version

English Version